Agree PAR seems to be within 12 months of a multi-bag particularly if you bought in the last 2 months. Stars seem to be aligning... however a few questions:
- What do we know about those who did not complete phase 2/1?
- How many? Who were they?
- What do we know about those who had no response or got worse?
- What do we know about side effects, toxicity of the treatment?
- Has anyone found patients from p1/p2 giving interviews / posting on social media?
- P3 aside, when do you expect the next cap raise to be? Have yet to try to work out what the rough expected cash requirement is vs. the costs and timing, seems like next cap raise likely to be announced within calendar q1 next year? This p3 is extensive, lot of execs to pay ...
- Forums
- ASX - By Stock
- PAR
- The Phase III Primer!
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.76%
!
33.3¢

The Phase III Primer!, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
33.3¢ |
Change
0.003(0.76%) |
Mkt cap ! $132.1M |
Open | High | Low | Value | Volume |
32.5¢ | 35.0¢ | 31.8¢ | $314.4K | 970.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 53063 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 9516 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 51374 | 0.330 |
6 | 56436 | 0.325 |
11 | 209618 | 0.320 |
12 | 64875 | 0.315 |
3 | 47072 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 25737 | 5 |
0.340 | 20701 | 8 |
0.345 | 3531 | 2 |
0.350 | 20459 | 5 |
0.355 | 38092 | 5 |
Last trade - 14.37pm 07/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |